The Alexander Firm P.C. Announces Investigation of Chindex International, Inc. and Its Board of Directors

The Alexander Firm P.C., A Professional Law Corporation, announces that it is investigating potential claims for breach of fiduciary duty against the Board of Directors of Chindex International, Inc. (“Chindex” or the “Company”) (NASDAQ:CHDX) concerning the proposed acquisition of the Company by an affiliate of TPG, Fosun Industrial Co., Limited (which is an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Ms. Roberta Lipson, the CEO of the Company (the “Buyer Consortium”). According to the Company, the transaction is currently valued at $24.00 per share in cash and implied equity value of $461 million.

Chindex is an American healthcare company which provides services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics. This investigation concerns whether the Board of Directors of Chindex breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, whether the Buyer Consortium is underpaying for Chindex shares, and whether or not the Company has disclosed all material information to shareholders about the transaction.

If you are a shareholder of Chindex, if you have information or would like to learn more about our investigation, or if you wish to discuss these matters or have any questions concerning this announcement, or your rights or interests with respect to these matters, please contact Vahn Alexander, Esq., The Alexander Firm P.C., A Professional Law Corporation, 1875 Century Park East, Suite 700, Los Angeles, California 90067, by telephone at (310) 407-5335, or by email to info@alexanderfirmpc.com, or visit our website at www.alexanderfirmpc.com. With 20 years of class action and complex litigation experience, The Alexander Firm is committed to protecting the rights of investors throughout the Country. This press release may be considered Attorney Advertising in some jurisdictions.